Showing results (21-30 of 235) with videos related to
Sort By:
Pageof 24
Nature Reviews. Neurology|September 8, 2022
Towards a global view of multiple sclerosis geneticsBenjamin Meir Jacobs, Michelle Peter, Gavin Giovannoni, et al.Neurobiology of Aging|December 15, 2010
A novel presenilin 1 mutation, I202F occurring at a previously predicted pathogenic site causing autosomal dominant Alzheimer's diseaseAlistair Church, Junita Prescott, Suzanne Lillis, et al.The Lancet. Neurology|September 15, 2025
The temporal order of genetic, environmental, and pathological risk factors in Parkinson's disease: paving the way to preventionCornelis Blauwendraat, Huw R Morris, Kendall Van Keuren-Jensen, et al.Journal of Alzheimer'S Disease : JAD|November 20, 2014
Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-associated familial Alzheimer's diseaseNatalie S Ryan, Tammaryn Lashley, Tamas Revesz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 30, 2011
Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic reviewKathryn J Peall, Adrian J Waite, Derek J Blake, et al.Neurobiology of Aging|September 5, 2017
Establishing the role of rare coding variants in known Parkinson's disease risk lociIris E Jansen, J Raphael Gibbs, Mike A Nalls, et al.Molecular Neurodegeneration|August 27, 2015
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutationAoife P Kiely, Helen Ling, Yasmine T Asi, et al.Journal of Neurology|March 5, 2009
The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based studyMark Wardle, Elisa Majounie, Mustapha B Muzaimi, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2011
Quality of life in young- compared with late-onset Parkinson's diseaseM Duleeka W Knipe, Mirdhu M Wickremaratchi, Emma Wyatt-Haines, et al.Joint Bone Spine|May 13, 2008
Interleukin-1 receptor antagonist gene polymorphisms are associated with disease severity in Black South Africans with rheumatoid arthritisSteven Lubbe, Mohammed Tikly, Lize van der Merwe, et al.Pageof 24